Addressing Residual Risk in Ischaemic Heart Disease with Anti-Inflammatory Drugs: Between Scylla and Charybdis

Filippo Crea

Research output: Contribution to journalArticle

Abstract

N/A
Original languageEnglish
Pages (from-to)2715-2719
Number of pages5
JournalEuropean Heart Journal
Volume42
DOIs
Publication statusPublished - 2021

Keywords

  • Anti-Inflammatory Agents
  • Coronary Artery Disease
  • Humans
  • Myocardial Ischemia
  • Pharmaceutical Preparations

Fingerprint

Dive into the research topics of 'Addressing Residual Risk in Ischaemic Heart Disease with Anti-Inflammatory Drugs: Between Scylla and Charybdis'. Together they form a unique fingerprint.

Cite this